Table 1.
Population | Assay date | N | LC50 (µg µL−1) | 95% CIa | χ 2 b | PR > χ 2 |
---|---|---|---|---|---|---|
Early emergence | ||||||
Arlington | 9 June | 225 | 0.0052 | (0.00051–0.021) | 19.43 | <0.0001 |
Arlington | 13 June | 225 | 0.058 | (0.0015–0.61) | 8.35 | 0.0038 |
Arlington | 21 June | 270 | 0.15 | (0.0100.73) | 11.47 | 0.0007 |
Arlington | 25 June | 270 | 0.099 | (NA*) | 3.80 | 0.051 |
Arlington | 29 June | 180 | 0.021 | (NA*–0.14) | 11.62 | 0.0006 |
Systemic‐3 | 9 June | 225 | 1.5 | (0.18–19) | 7.28 | 0.007 |
Systemic‐3 | 13 June | 225 | 3.5 | (1.1–53) | 13.54 | 0.0002 |
Systemic‐3 | 21 June | 270 | 7.5 | (3.0–49) | 19.53 | <0.0001 |
Systemic‐3 | 25 June | 270 | 7.5 | (4.5–19) | 26.29 | <0.0001 |
Systemic‐3 | 29 June | 180 | 2.4 | (1.6–3.8) | 32.28 | <0.0001 |
Late emergence | ||||||
Arlington | 25 June | 270 | 0.18 | (0.13–0.24) | 23.79 | <0.0001 |
Arlington | 29 June | 270 | 0.23 | (0.067–0.68) | 11.56 | 0.0007 |
Arlington | 3 July | 270 | 0.073 | (NA*–0.24) | 4.96 | 0.030 |
Arlington | 6 July | 270 | 0.099 | (0.0059–0.40) | 10.50 | 0.0012 |
Arlington | 10 July | 270 | 0.11 | (0.015–0.55) | 14.31 | 0.0002 |
Arlington | 14 July | 90 | 0.18 | (0.020–13) | 8.73 | 0.0031 |
Systemic‐3 | 25 June | 270 | 6.8 | (5.5–10) | 11.11 | 0.0009 |
Systemic‐3 | 29 June | 270 | 8.7 | (6.3–30) | 8.29 | 0.004 |
Systemic‐3 | 3 July | 270 | 8.7 | (6.0–13.9) | 9.84 | 0.0017 |
Systemic‐3 | 6 July | 270 | 11 | (4.7–40) | 4.79 | 0.028 |
Systemic‐3 | 10 July | 270 | 9.0 | (2.4–15) | 5.62 | 0.017 |
Systemic‐3 | 14 July | 180 | 4.1 | (3.1–5.5) | 46.31 | <0.0001 |
Conclusion of first generation | ||||||
Arlington | 10 July | 180 | 0.18 | (0.12–0.27) | 20.73 | <0.0001 |
Arlington | 14 July | 180 | 0.14 | (0.063–0.36) | 28.32 | <0.0001 |
Arlington | 18 July | 90 | 0.030 | (NA*) | 2.68 | 0.10 |
Sytemic‐3 | 10 July | 180 | 5.7 | (4.2–8.9) | 29.14 | <0.0001 |
Sytemic‐3 | 14 July | 180 | 8.7 | (0.050–23) | 4,7 | 0.03 |
Sytemic‐3 | 18 July | 90 | 5.3 | (3.7–8.3) | 19.81 | <0.0001 |
Second generation | ||||||
Arlington | 21 July | 270 | 0.28 | (0.016–1.3) | 5.65 | 0.017 |
Systemic‐3 | 21 July | 270 | 8.4 | (4.1–20) | 19.18 | <0.0001 |
Systemic‐3 | 27 August | 270 | 15 | (7.0–28) | 16.58 | <0.0001 |
Systemic‐3 | 10 September | 270 | 14 | (4.9–28) | 13.77 | 0.0002 |
95% confidence interval (CI) estimates around mean LC50 estimates.
Chi‐square analysis of effects of the proc probit regression.
NA represents a probit mortality regression estimate without a 95% confidence interval (CI).